Not yet recruiting
Interstitial lung disease+1
Not yet recruitingSafety and Efficacy of Mirivadelgat Compared with Placebo in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease
Investigational
Safety and Efficacy of Mirivadelgat Compared with Placebo in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease
Investigational
- Disease:Interstitial lung diseasePulmonary hypertension
- Substances:–
Countries:
Czechia
Czechia- Participants:18–64 years · 65+ years
- Sponsor:Foresee Pharmaceuticals USA Inc.



